Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PSCA Antikörper

PSCA Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7254328
  • Target Alle PSCA Antikörper anzeigen
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Reaktivität
    • 60
    • 20
    • 10
    • 2
    • 2
    • 2
    Human, Maus
    Wirt
    • 51
    • 9
    • 1
    Kaninchen
    Klonalität
    • 53
    • 8
    Polyklonal
    Konjugat
    • 35
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PSCA Antikörper ist unkonjugiert
    Applikation
    • 46
    • 18
    • 13
    • 13
    • 10
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Produktmerkmale
    Polyclonal Antibody
    Aufreinigung
    Antigen affinity purification
    Immunogen
    Synthetic peptide of human PSCA
    Isotyp
    IgG
    Top Product
    Discover our top product PSCA Primärantikörper
  • Applikationshinweise
    WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.78 mg/mL
    Buffer
    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Andere Bezeichnung
    PSCA (PSCA Produkte)
    Hintergrund
    PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
    Molekulargewicht

    Observed_MW: Refer to figures

    Calculated_MW: 13 kDa

    UniProt
    O43653
Sie sind hier:
Kundenservice